A Growing Global Health Threat
Dr. Hogan explained that AMR occurs when microbes (bacteria, fungi, and others) evolve to withstand antibiotics that once killed them. This leads to “superbugs” that render standard treatments ineffective. Common infections—such as urinary tract infections or minor wounds—can now escalate rapidly, sometimes fatally.
He highlighted contributing factors:
- Overuse in agriculture — Approximately 60% of antibiotics are used in livestock, leading to environmental dissemination through soil, water, and runoff, and eventual human exposure via the food chain.
- Healthcare infrastructure challenges — Post-COVID strains on rural hospitals limit timely access to care, particularly in states like South Dakota with vast rural areas divided by geography like the Missouri River.
- Limited innovation — Few new antibiotics have reached the market in recent decades due to low profitability compared to other disease areas, despite the urgent need.
South Dakota sits at a moderate risk level, according to Dr. Hogan. The state benefits from strong health systems and proactive reporting to the CDC, but higher antibiotic prescribing rates and rural access gaps increase vulnerability.
Interconnected Systems: From Farm to Clinic
The discussion underscored AMR’s interdisciplinary nature. In an agriculture-driven state like South Dakota, high-density livestock production amplifies risks of resistant bacteria spreading through manure and the environment. Dr. Hogan stressed the full ecosystem connection:
- Proper antibiotic adherence (completing full courses) prevents resistant strains from flourishing.
- Everyday hygiene—handwashing, proper food handling, and infection prevention (e.g., alcohol swabs for injections or pre-surgical protocols)—plays a critical role.
- As populations age, with more seniors at higher risk, small exposures can have outsized consequences.
He noted historical parallels: pandemics are not anomalies but recurring events, from the Spanish Flu to earlier global outbreaks. Today’s hyper-connected world accelerates spread, making preparedness essential.
Innovation as Opportunity
Dr. Hogan views AMR as a ripe area for disruption. Opportunities exist in:
- New therapeutics and pharma development.
- Data and AI tools to improve reporting, surveillance, and communication of AMR impacts (often masked under labels like “sepsis” or “UTI”).
- AI in healthcare — A net positive for analysis, patient education, and decision support, though best used in moderation alongside clinical guidance.
The conversation aligned with broader themes of pandemic preparedness, echoing recent discussions in South Dakota around national security, biotech investment, and resilient health systems.
Listen to the Full Conversation
The conversation with Dr. Hogan highlights why antimicrobial resistance deserves greater attention from researchers, healthcare leaders, and innovation ecosystems alike.
As global health systems prepare for future pandemics, understanding and addressing AMR will be critical to protecting long-term public health.
To hear the full discussion, listen to Episode 17 of Favorable Environments on your favorite podcast player.